about
Pituitary production of prolactin and prolactin-suppressing drugs.Evaluation of factors affecting CGMS calibration.Longitudinal assessment of neuroanatomical and cognitive differences in young children with type 1 diabetes: association with hyperglycemia.A randomized clinical trial to assess the efficacy and safety of real-time continuous glucose monitoring in the management of type 1 diabetes in young children aged 4 to <10 years.Persistently high glucose levels in young children with type 1 diabetesAccuracy of the modified Continuous Glucose Monitoring System (CGMS) sensor in an outpatient setting: results from a diabetes research in children network (DirecNet) study.Variations in Brain Volume and Growth in Young Children With Type 1 Diabetes.FreeStyle navigator continuous glucose monitoring system use in children with type 1 diabetes using glargine-based multiple daily dose regimens: results of a pilot trial Diabetes Research in Children Network (DirecNet) Study Group.Longitudinal Evaluation of Cognitive Functioning in Young Children with Type 1 Diabetes over 18 MonthsLow-fat vs. high-fat bedtime snacks in children and adolescents with type 1 diabetes.Factors associated with microalbuminuria in 7,549 children and adolescents with type 1 diabetes in the T1D Exchange clinic registry.Variants of the dopamine D2 receptor gene and risperidone-induced hyperprolactinemia in children and adolescents.Weight gain and metabolic abnormalities during extended risperidone treatment in children and adolescents.Alterations in white matter structure in young children with type 1 diabetesEffects of moderate-to-vigorous intensity physical activity on overnight and next-day hypoglycemia in active adolescents with type 1 diabetes.Satisfaction with continuous glucose monitoring in adults and youths with Type 1 diabetes.Extended 6-month follow-up of a randomized clinical trial to assess the efficacy and safety of real-time continuous glucose monitoring in the management of type 1 diabetes in young children aged 4 to <10 years.Function of the GlucoWatch G2 Biographer during exercise.Continuous glucose monitoring and intensive treatment of type 1 diabetes.Congenital hypothyroidism with delayed thyroid-stimulating hormone elevation in premature infants born at less than 30 weeks gestation.Vitamin D Toxicity: A 16-Year Retrospective Study at an Academic Medical Center.Cross-Validation of Single-Stage Treadmill Tests for Predicting Aerobic Fitness in Adolescents with Type I Diabetes.Aerobic fitness and glycemic variability in adolescents with type 1 diabetes.An autoimmune disease risk SNP, rs2281808, in SIRPG is associated with reduced expression of SIRPγ and heightened effector state in human CD8 T-cellsDouble paternal nondisjunction in an infant with transient neonatal diabetes mellitus and Klinefelter syndromeA 36-year retrospective analysis of the efficacy and safety of radioactive iodine in treating young Graves' patientsLongitudinal assessment of hippocampus structure in children with type 1 diabetesAutoimmunity-associated intronic SNP (rs2281808) detected by a simple phenotypic assay: Unique case or broader opportunity?Individual glucose responses to prolonged moderate intensity aerobic exercise in adolescents with type 1 diabetes: The higher they start, the harder they fall
P50
Q34447934-2045F57A-056D-42C4-9774-6E2E42157534Q34700508-E95C7858-E4CF-4D8D-B153-22FF27A29ACCQ35532237-C405BECF-6B15-4EE9-AD9C-490C15BF74FAQ35688182-426AAF4D-1825-4EBC-9F2D-8A7333E2225AQ35736216-CA11F6F0-4A3C-48CA-896B-90BB3F4C4DCFQ36478852-2CD8ED4B-CD28-4F5C-A975-FEB955E3E7E8Q36562543-1994E958-A71B-4134-987D-0803BFD8F38BQ36627309-9BF9F8F5-4ECC-4778-87CA-89F33509EBFDQ36868967-AA5D9E27-9B7C-496A-AA08-78F51E9854A4Q36996085-97AC82D4-A2B8-4DFE-B67E-C9733F60AFA4Q37106486-BE1C2DCE-5979-49C4-B9D9-6152FEAFC638Q37236402-8FDD0B59-339B-4A66-8784-A87A295E183CQ37273061-328522E0-2A9C-40FB-9826-297B2B32CA01Q37504098-DE6CAA53-1293-4D43-AB47-87F11705512AQ37715548-80300C23-CEC4-4B56-9648-1F889AED80EDQ42605976-B8E0B0FB-CEAF-40F3-9C81-EC96DAFA4845Q43189388-ECED6457-BAC7-4342-B504-6B5FCB83AF93Q45288083-C9A6E120-9417-483E-A861-C3A24046BF3DQ46380752-F57DD5A6-205E-439C-8DC0-C2A45B4A2F8DQ47618087-D477F38B-3193-4BAE-BF3D-8122EBF9B0B4Q49963934-CE802E9C-9C48-4CF0-9E22-AFCCE19D2527Q50881323-CB2C97C9-0B4A-42AD-8E72-A8C34E0BCFD2Q53635250-3E18756F-CE18-462A-BA32-5734F15674E5Q58603070-1339B824-884F-4A2A-BB04-1356282721AEQ79967524-61B5CCAF-8AE4-42A2-BACE-0A9139B1C7E5Q80542207-CB96F86A-6139-4F78-969D-F8B2AFF6B7DFQ88418267-F7A01E55-4BE7-4024-AD01-3A78C1FBA6F8Q90720683-922116ED-4771-44E5-AF15-0E79A294B08FQ93364768-8EA5D4B6-E65D-4A21-8F03-05AB15A899EA
P50
description
researcher ORCID ID = 0000-0002-8157-8423
@en
wetenschapper
@nl
name
Michael Tansey
@ast
Michael Tansey
@en
Michael Tansey
@es
Michael Tansey
@nl
type
label
Michael Tansey
@ast
Michael Tansey
@en
Michael Tansey
@es
Michael Tansey
@nl
prefLabel
Michael Tansey
@ast
Michael Tansey
@en
Michael Tansey
@es
Michael Tansey
@nl
P1153
8613849100
P21
P31
P496
0000-0002-8157-8423